TI
CAPR icon

Trexquant Investment’s Capricor Therapeutics CAPR Stock Holding History

Trexquant Investment’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.76M Sell
197,793
-24,620
-11% -$746K 0.03% 772
2026
Q1 		$6.76M Buy
+222,413
New +$5.93M 0.05% 532
2024
Q3 		– Sell
-18,879
Closed -$90.1K – 1550
2024
Q2 		$90.1K Buy
+18,879
New +$105K ﹤0.01% 1473

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Trexquant Investment's CAPR Position: Q2 2026 in Review

Trexquant Investment reduced its Capricor Therapeutics (CAPR) stake by 11% in Q2 2026, selling an estimated $746K and leaving 197,793 shares worth $4.76M. The position accounts for 0.03% of the portfolio, ranked #772.

Trexquant Investment first reported a position in CAPR in Q2 2024 and has held it in 3 quarters since. The position peaked at $6.76M in Q1 2026. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Trexquant Investment held 197,793 shares of Capricor Therapeutics worth $4.76M as of Q2 2026.
  • Trexquant Investment sold 24,620 Capricor Therapeutics shares in Q2 2026, an estimated $746K.
  • Capricor Therapeutics made up 0.03% of Trexquant Investment's portfolio in Q2 2026, its #772 holding.
  • Trexquant Investment first reported a position in Capricor Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • Trexquant Investment's Capricor Therapeutics position peaked at $6.76M in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.